Rybelsus Near Me: Clinics, Pharmacies and Telehealth by State

Rybelsus in brief

How long the drug stays in your body

Its half-life is about 1 week: after 7 d, half is gone, and five half-lives (35 d) leave about 3% behind.

How much weight came off in the main trial

In PIONEER 1, people with type 2 diabetes lost 3.7 kg over 26 weeks, while placebo gave 1.4 kg.

What the price looks like over time

Prices in US dollars for each month cover the list price and self-pay offers, and every figure comes from the maker's price page.

Sources: FDA label (DailyMed), healthsystemtracker.org, Novo Nordisk pricing, Novo Nordisk.

Every legit route to Rybelsus, ranked

Ways to get it, lowest cost first
Route	Who it is for	What you pay
Your doctor, with insurance and the savings card	Commercial insurance that covers it	Pay as little as $25 for a 1, 2 or 3 month fill

Prices checked November 2026. Each listed price links to the page it came from.

Sources: Novo Nordisk pricing, rybelsus.com, FDA.

Who qualifies

Every GLP-1 needs a prescription in the US. A prescriber writes it for a use that is approved on the label:

Blood sugar goes down for adults with type 2 diabetes when they use it alongside diet and exercise.
It lowers the risk of death from heart problems, a heart attack, or a stroke for adults with type 2 diabetes at high risk.

RequiredFDA label on DailyMed

Shortage status

The injection shortage for semaglutide was resolved on February 21, 2025. The older Rybelsus tablets are being discontinued.

Semaglutide supply for each product
Product	FDA status	Availability
Rybelsus tablet 3 mg, 7 mg, 14 mg	To Be Discontinued	Replaced by Ozempic (semaglutide) tablets

First added to the FDA shortage list: March 2022
Shortage resolved: February 21, 2025
State pharmacies had to stop compounding copies: April 22, 2025
Outsourcing facilities had to stop on May 22, 2025

Sources: FDA, api.fda.gov.

Scam signals

No prescription needed: sellers who skip it are not licensed pharmacies in the US.
FDA does not approve compounded drugs, including those sold as the brand. They are not Ozempic, Wegovy, Mounjaro or Zepbound.
Other salt forms: semaglutide acetate and semaglutide sodium differ from the active ingredient used in products that are approved.
The FDA sent 30 warning letters to telehealth companies about misleading claims of being identical to the brand product.
Harm reports: the FDA has 990 adverse event reports on file that link to compounded semaglutide.
The FTC acted against one program because its monthly price left out the drug; see the NextMed review.

Sources: Novo Nordisk pricing, rybelsus.com, FDA.

Find it in your state

Hims & Hers: coverage does not reach all 50 states
Noom Med: coverage does not reach all 50 states
NovoCare Pharmacy: its delivery network reaches DC, Puerto Rico and all 50 states

The route changes most under Medicaid rules. the route you take depends mostly on Medicaid rules. Right now, 10 state Medicaid programs cover GLP-1s for weight loss. Select your state to see the drug list and prior authorization rules:

Sources: hims.com, noom.com, NovoCare.